Allston, MA, United States of America

Jeremy Lopez

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Syros Pharmaceuticals, Inc.. Active years: 2017-2022.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Jeremy Lopez in Patient Treatment

Introduction

Jeremy Lopez is an accomplished inventor based in Allston, MA (US). He has made significant contributions to the field of medicine, particularly in the development of methods for patient treatment. With a total of 4 patents to his name, Lopez is recognized for his innovative approaches to healthcare.

Latest Patents

One of Lopez's latest patents focuses on "Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonists." This invention provides methods that define cellular populations sensitive to RARA agonists and identifies patient subgroups that will benefit from treatment with these agonists. Additionally, the invention includes packaged pharmaceutical compositions that comprise a RARA agonist along with instructions for determining its suitability for treatment.

Career Highlights

Lopez is currently employed at Syros Pharmaceuticals, Inc., where he continues to advance his research and innovations. His work has the potential to significantly impact patient care and treatment outcomes.

Collaborations

Lopez collaborates with talented coworkers, including Mei Wei Chen and Cindy Collins, who contribute to the innovative environment at Syros Pharmaceuticals.

Conclusion

Jeremy Lopez's contributions to the field of medicine through his patents and work at Syros Pharmaceuticals highlight his commitment to improving patient treatment methods. His innovative approaches are paving the way for advancements in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…